The Blueprint for a New Era: Scaling Individualized CRISPR Therapies Post-Baby KJ
The medical landscape was irrevocably altered by the success of "Baby KJ," the first patient to undergo a pioneering, personalized...
therapies
Next-Generation T-Cell Therapies: Circio and Tcelltech Forge Strategic Alliance to Revolutionize In Vivo Gene Delivery
In a move poised to reshape the landscape of immuno-oncology, Norway-based biotech firm Circio and German precision engineering company Tcelltech...
